Corbus Pharmaceuticals Holdings IncNASDAQ:CRBP
- LAST PRICE48.5500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots47.6300/ 3
- Ask / Lots55.0000/ 6
- Open / Previous Close0.0000 / 48.5500
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRBP |
|---|---|---|
| 09:32 ET | 637 | 45 |
| 09:34 ET | 606 | 44.51 |
| 09:45 ET | 300 | 45.3 |
| 09:48 ET | 500 | 45.12 |
| 09:50 ET | 500 | 45.5925 |
| 09:57 ET | 400 | 45.59 |
| 10:01 ET | 100 | 45.63 |
| 10:08 ET | 1288 | 46.365 |
| 10:10 ET | 1176 | 46.4 |
| 10:12 ET | 1100 | 46.74 |
| 10:14 ET | 322 | 46.54 |
| 10:15 ET | 800 | 46.645 |
| 10:17 ET | 376 | 46.2 |
| 10:19 ET | 200 | 46.05 |
| 10:24 ET | 1152 | 45.92 |
| 10:26 ET | 1033 | 45.91 |
| 10:28 ET | 136 | 45.91 |
| 10:30 ET | 936 | 45.46 |
| 10:32 ET | 300 | 45.6844 |
| 10:35 ET | 100 | 45.86 |
| 10:37 ET | 100 | 45.875 |
| 10:44 ET | 100 | 45.965 |
| 10:46 ET | 233 | 46 |
| 10:48 ET | 100 | 46.07 |
| 10:50 ET | 200 | 46.16 |
| 11:00 ET | 100 | 46.24 |
| 11:02 ET | 100 | 46.53 |
| 11:20 ET | 100 | 46.49 |
| 11:22 ET | 51000 | 46.31 |
| 11:24 ET | 200 | 46.325 |
| 11:26 ET | 300 | 46.37 |
| 11:27 ET | 333 | 46.445 |
| 11:31 ET | 300 | 46.39 |
| 11:33 ET | 400 | 46.18 |
| 11:36 ET | 100 | 46.07 |
| 11:38 ET | 100 | 46.19 |
| 11:44 ET | 1393 | 45.85 |
| 11:45 ET | 433 | 46.08 |
| 11:47 ET | 100 | 46.085 |
| 11:49 ET | 225 | 46.07 |
| 11:51 ET | 200 | 46.09 |
| 11:54 ET | 426 | 45.965 |
| 11:58 ET | 425 | 46.08 |
| 12:00 ET | 100 | 46.12 |
| 12:02 ET | 836 | 46.62 |
| 12:03 ET | 500 | 46.68 |
| 12:05 ET | 200 | 46.735 |
| 12:07 ET | 438 | 46.2641 |
| 12:09 ET | 100 | 46.71 |
| 12:12 ET | 100 | 46.705 |
| 12:14 ET | 11533 | 47.145 |
| 12:16 ET | 300 | 47.045 |
| 12:18 ET | 500 | 47.385 |
| 12:20 ET | 750 | 47.35 |
| 12:21 ET | 200 | 47.41 |
| 12:23 ET | 611 | 47.34 |
| 12:25 ET | 800 | 47.37 |
| 12:27 ET | 1117 | 47.3 |
| 12:30 ET | 2114 | 47.2 |
| 12:32 ET | 100 | 47.27 |
| 12:36 ET | 100 | 47.29 |
| 12:38 ET | 300 | 47.39 |
| 12:39 ET | 200 | 47.17 |
| 12:41 ET | 588 | 47.46 |
| 12:43 ET | 300 | 47.3061 |
| 12:45 ET | 408 | 47.33 |
| 12:48 ET | 300 | 47.4521 |
| 12:50 ET | 500 | 47.145 |
| 12:54 ET | 1700 | 47.441 |
| 12:56 ET | 800 | 47.295 |
| 01:01 ET | 200 | 47.39 |
| 01:03 ET | 100 | 47.355 |
| 01:06 ET | 250 | 47.36 |
| 01:08 ET | 100 | 47.47 |
| 01:10 ET | 298 | 47.43 |
| 01:12 ET | 300 | 47.38 |
| 01:14 ET | 1994 | 47.27 |
| 01:15 ET | 100 | 47.14 |
| 01:21 ET | 500 | 47.28 |
| 01:24 ET | 100 | 47.4 |
| 01:26 ET | 20789 | 48.58 |
| 01:28 ET | 400 | 48.38 |
| 01:30 ET | 1520 | 48.465 |
| 01:33 ET | 300 | 48.4 |
| 01:35 ET | 979 | 48.6295 |
| 01:37 ET | 100 | 48.44 |
| 01:39 ET | 900 | 48.405 |
| 01:42 ET | 100 | 48.375 |
| 01:44 ET | 200 | 48.385 |
| 01:46 ET | 400 | 48.195 |
| 01:48 ET | 200 | 48.37 |
| 01:50 ET | 1096 | 48.275 |
| 01:51 ET | 100 | 48.04 |
| 01:55 ET | 476 | 48.24 |
| 01:57 ET | 100 | 48.245 |
| 02:00 ET | 1000 | 48.24 |
| 02:02 ET | 294 | 48.35 |
| 02:04 ET | 560 | 48.2616 |
| 02:06 ET | 762 | 48.35 |
| 02:08 ET | 200 | 48.23 |
| 02:09 ET | 2196 | 48.43 |
| 02:11 ET | 100 | 48.4 |
| 02:13 ET | 400 | 48.28 |
| 02:20 ET | 350 | 48.125 |
| 02:22 ET | 5579 | 47.9 |
| 02:24 ET | 1626 | 48.06 |
| 02:27 ET | 636 | 48 |
| 02:29 ET | 500 | 48 |
| 02:31 ET | 100 | 48.18 |
| 02:33 ET | 400 | 47.89 |
| 02:36 ET | 2449 | 48.14 |
| 02:38 ET | 100 | 48.095 |
| 02:40 ET | 300 | 48.28 |
| 02:42 ET | 2118 | 48.22 |
| 02:44 ET | 300 | 48.31 |
| 02:45 ET | 500 | 48.22 |
| 02:47 ET | 1610 | 47.92 |
| 02:54 ET | 100 | 48.045 |
| 02:58 ET | 200 | 48.18 |
| 03:00 ET | 500 | 48.2 |
| 03:02 ET | 400 | 48.26 |
| 03:03 ET | 200 | 48.31 |
| 03:05 ET | 200 | 48.225 |
| 03:07 ET | 200 | 48.3 |
| 03:09 ET | 400 | 48.37 |
| 03:12 ET | 506 | 48.36 |
| 03:14 ET | 1095 | 48.205 |
| 03:16 ET | 500 | 48.155 |
| 03:18 ET | 500 | 48.0775 |
| 03:20 ET | 13233 | 48.03 |
| 03:23 ET | 374 | 48.085 |
| 03:25 ET | 1700 | 48.22 |
| 03:27 ET | 200 | 48.22 |
| 03:30 ET | 189 | 48.185 |
| 03:32 ET | 3078 | 48.1 |
| 03:34 ET | 300 | 48.135 |
| 03:36 ET | 100 | 48.15 |
| 03:38 ET | 1000 | 48.229 |
| 03:39 ET | 3926 | 48.4191 |
| 03:41 ET | 16477 | 48.505 |
| 03:43 ET | 3491 | 48.844 |
| 03:45 ET | 18937 | 49 |
| 03:48 ET | 500 | 48.705 |
| 03:50 ET | 400 | 48.73 |
| 03:52 ET | 2100 | 48.465 |
| 03:54 ET | 1000 | 48.455 |
| 03:56 ET | 1636 | 48.47 |
| 03:57 ET | 2415 | 48.295 |
| 03:59 ET | 12664 | 48.55 |
May 13, 2024
DJ Corbus Pharmaceuticals Initiated at Outperform by RBC Capital, from 7:34AM ET on Monday May 13, 2024 by Dow Jones
7:34AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
DJ Corbus Pharmaceuticals Currently Up Nine Consecutive Days, on Track for Record Winning Streak -- Data Talk, from 2:52PM ET on Wednesday May 08, 2024 by Dow Jones
2:52PM ET on Wednesday May 08, 2024 by Dow JonesDJ Corbus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 12:04PM ET on Wednesday May 08, 2024 by Dow Jones
12:04PM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 8:01AM ET on Tuesday May 07, 2024 by Dow Jones
8:01AM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 518.8M | -7.0x | --- |
Celcuity Inc | 524.7M | -6.0x | --- |
Astria Therapeutics Inc | 526.6M | -4.1x | --- |
Korro Bio Inc | 506.3M | -1.3x | --- |
Olema Pharmaceuticals Inc | 532.5M | -4.7x | --- |
Erasca Inc | 533.1M | -2.7x | --- |
Company Information
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Contact Information
- Headquarters
- 500 River Ridge DriveNORWOOD, MA, United States 02062
- Phone
- 617-963-0103
- Fax
- ---
Executives
- Independent Director
- Alan Holmer
- Chief Executive Officer, Director
- Yuval Cohen
- Chief Financial Officer
- Sean Moran
- Chief Medical Officer
- Dominic Smethurst
- Independent Director
- Anne Altmeyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $518.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.56 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -7.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
